Compare GPMT & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | SERA |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | United States |
| Employees | 28 | 72 |
| Industry | Real Estate Investment Trusts | Precision Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 75.2M |
| IPO Year | N/A | 2021 |
| Metric | GPMT | SERA |
|---|---|---|
| Price | $1.51 | $1.88 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 119.7K | 20.1K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 12.99% | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $81,000.00 |
| Revenue This Year | $458.85 | $554.81 |
| Revenue Next Year | $8.63 | $517.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.19 |
| 52 Week Low | $1.24 | $1.37 |
| 52 Week High | $3.12 | $4.09 |
| Indicator | GPMT | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 50.65 | 41.57 |
| Support Level | $1.24 | $1.72 |
| Resistance Level | $1.66 | $2.41 |
| Average True Range (ATR) | 0.08 | 0.18 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 54.01 | 37.68 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.